These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27553659)

  • 1. Role of vasoactive intestinal peptide in osteoarthritis.
    Jiang W; Wang H; Li YS; Luo W
    J Biomed Sci; 2016 Aug; 23(1):63. PubMed ID: 27553659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.
    Pérez-García S; Carrión M; Gutiérrez-Cañas I; González-Álvaro I; Gomariz RP; Juarranz Y
    J Cell Mol Med; 2016 Apr; 20(4):678-87. PubMed ID: 26818776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
    Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
    Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of synovial fluid and articular cartilage VIP in human osteoarthritic knee: a new indicator of disease severity?
    Jiang W; Gao SG; Chen XG; Xu XC; Xu M; Luo W; Tu M; Zhang FJ; Zeng C; Lei GH
    Clin Biochem; 2012 Dec; 45(18):1607-12. PubMed ID: 22959974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide alleviates osteoarthritis effectively via inhibiting NF-κB signaling pathway.
    Liang Y; Chen S; Yang Y; Lan C; Zhang G; Ji Z; Lin H
    J Biomed Sci; 2018 Mar; 25(1):25. PubMed ID: 29540226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis.
    Schuelert N; McDougall JJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1155-62. PubMed ID: 16740398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells.
    Juarranz MG; Santiago B; Torroba M; Gutierrez-Cañas I; Palao G; Galindo M; Abad C; Martinez C; Leceta J; Pablos JL; Gomariz RP
    Rheumatology (Oxford); 2004 Apr; 43(4):416-22. PubMed ID: 14657510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis.
    McDougall JJ; Watkins L; Li Z
    Pain; 2006 Jul; 123(1-2):98-105. PubMed ID: 16564620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide ameliorates synovial cell functions of collagen-induced arthritis rats by down-regulating NF-kappaB activity.
    Yin H; Cheng H; Yu M; Zhang F; Lin J; Gao Y; Han B; Zhu L
    Immunol Invest; 2005; 34(2):153-69. PubMed ID: 15921157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vasoactive intestinal peptide in the progression of osteoarthritis through bone sclerosis and angiogenesis in subchondral bone.
    Kanemitsu M; Nakasa T; Shirakawa Y; Ishikawa M; Miyaki S; Adachi N
    J Orthop Sci; 2020 Sep; 25(5):897-906. PubMed ID: 31928851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts.
    Arranz A; Gutiérrez-Cañas I; Carrión M; Juarranz Y; Pablos JL; Martínez C; Gomariz RP
    Mol Immunol; 2008 Jun; 45(11):3065-73. PubMed ID: 18452992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of vasoactive intestinal peptide to immune homeostasis in trophoblast-maternal leukocyte interaction under LPS stimulation.
    Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Pérez Leirós C; Ramhorst R
    Neuroimmunomodulation; 2014; 21(1):21-30. PubMed ID: 24135863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica.
    Pulsatelli L; Dolzani P; Silvestri T; De Giorgio R; Salvarani C; Macchioni P; Frizziero L; Meliconi R
    Clin Exp Rheumatol; 2006; 24(5):562-6. PubMed ID: 17181926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis.
    Pérez-García S; Calamia V; Hermida-Gómez T; Gutiérrez-Cañas I; Carrión M; Villanueva-Romero R; Castro D; Martínez C; Juarranz Y; Blanco FJ; Gomariz RP
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis.
    Nguyen LT; Sharma AR; Chakraborty C; Saibaba B; Ahn ME; Lee SS
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts.
    Gutiérrez-Cañas I; Juarranz Y; Santiago B; Arranz A; Martinez C; Galindo M; Payá M; Gomariz RP; Pablos JL
    Rheumatology (Oxford); 2006 May; 45(5):527-32. PubMed ID: 16319097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators alter interleukin-17 receptor, interleukin-12 and -23 expression in human osteoarthritic and rheumatoid arthritis synovial fibroblasts: immunomodulation by vasoactive intestinal Peptide.
    Carrión M; Pérez-García S; Jimeno R; Juarranz Y; González-Álvaro I; Pablos JL; Gutiérrez-Cañas I; Gomariz RP
    Neuroimmunomodulation; 2013; 20(5):274-84. PubMed ID: 23880957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.
    Pérez-García S; Juarranz Y; Carrión M; Gutiérrez-Cañas I; Margioris A; Pablos JL; Tsatsanis C; Gomariz RP
    J Cell Physiol; 2011 Dec; 226(12):3261-9. PubMed ID: 21360527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis.
    Sutton S; Clutterbuck A; Harris P; Gent T; Freeman S; Foster N; Barrett-Jolley R; Mobasheri A
    Vet J; 2009 Jan; 179(1):10-24. PubMed ID: 17911037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury.
    Luo Q; Wang Y; Feng D; Xu Y; Xu L
    Eur J Pharmacol; 2009 Apr; 607(1-3):226-33. PubMed ID: 19222997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.